CL2023001439A1 - Procedimiento para preparar 7-cloro-6-fluoro-1-(2-isopropil-4-metilpiridin-3-il)pirido[2,3-d]pirimidino-2,4(1h,3h)-diona - Google Patents
Procedimiento para preparar 7-cloro-6-fluoro-1-(2-isopropil-4-metilpiridin-3-il)pirido[2,3-d]pirimidino-2,4(1h,3h)-dionaInfo
- Publication number
- CL2023001439A1 CL2023001439A1 CL2023001439A CL2023001439A CL2023001439A1 CL 2023001439 A1 CL2023001439 A1 CL 2023001439A1 CL 2023001439 A CL2023001439 A CL 2023001439A CL 2023001439 A CL2023001439 A CL 2023001439A CL 2023001439 A1 CL2023001439 A1 CL 2023001439A1
- Authority
- CL
- Chile
- Prior art keywords
- compound
- methylpyridin
- isopropyl
- procedure
- fluoro
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 229940126062 Compound A Drugs 0.000 abstract 3
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 abstract 2
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 abstract 2
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 abstract 2
- ZVYNUGSPFZCYEV-UHFFFAOYSA-N 2,6-dichloro-5-fluoropyridine-3-carboxamide Chemical compound NC(=O)C1=CC(F)=C(Cl)N=C1Cl ZVYNUGSPFZCYEV-UHFFFAOYSA-N 0.000 abstract 1
- VXPOAPWLMVAUCK-UHFFFAOYSA-N 4-methyl-2-propan-2-ylpyridin-3-amine Chemical compound C(C)(C)C1=NC=CC(=C1N)C VXPOAPWLMVAUCK-UHFFFAOYSA-N 0.000 abstract 1
- STGUDAKZZKATNY-UHFFFAOYSA-N CC(C)C1=NC=CC(C)=C1N=C=O Chemical compound CC(C)C1=NC=CC(C)=C1N=C=O STGUDAKZZKATNY-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960003966 nicotinamide Drugs 0.000 abstract 1
- 235000005152 nicotinamide Nutrition 0.000 abstract 1
- 239000011570 nicotinamide Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- NXQKSXLFSAEQCZ-SFHVURJKSA-N sotorasib Chemical compound FC1=CC2=C(N(C(N=C2N2[C@H](CN(CC2)C(C=C)=O)C)=O)C=2C(=NC=CC=2C)C(C)C)N=C1C1=C(C=CC=C1O)F NXQKSXLFSAEQCZ-SFHVURJKSA-N 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporciona en el presente documento un procedimiento para preparar el compuesto A que comprende (a) mezclar 2-isopropil-4-metilpiridin-3-amina (Compuesto B), o una sal de la misma, una primera base, y un compuesto reactivo que comprende fosgeno o un equivalente de fosgeno en un disolvente orgánico para formar 3-isocianato-2-isopropil-4-metilpiridina (Compuesto C); (b) mezclar el Compuesto C y 2,6-dicloro-5-fluoronicotinamida (Compuesto D) para formar 2,6-dicloro-5-fluoro-N-((2-isopropi1-4-metilpiridin-3-il)carbamoil)nicotinamida (Compuesto E); y (c) mezclar el Compuesto E y una segunda base para formar una mezcla de producto que comprende el Compuesto A y la segunda base. También se proporciona en el presente documento un procedimiento para sintetizar AMG 510 que comprende el uso del Compuesto A preparado según los procedimientos dados a conocer
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063116703P | 2020-11-20 | 2020-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2023001439A1 true CL2023001439A1 (es) | 2023-10-30 |
Family
ID=79024258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2023001439A CL2023001439A1 (es) | 2020-11-20 | 2023-05-18 | Procedimiento para preparar 7-cloro-6-fluoro-1-(2-isopropil-4-metilpiridin-3-il)pirido[2,3-d]pirimidino-2,4(1h,3h)-diona |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240025896A1 (es) |
| EP (1) | EP4247813A1 (es) |
| JP (1) | JP2023550386A (es) |
| KR (1) | KR20230110575A (es) |
| CN (1) | CN116507624A (es) |
| AR (1) | AR124105A1 (es) |
| AU (1) | AU2021382674A1 (es) |
| CA (1) | CA3201663A1 (es) |
| CL (1) | CL2023001439A1 (es) |
| IL (1) | IL302821A (es) |
| MX (1) | MX2023005823A (es) |
| TW (1) | TW202237598A (es) |
| WO (1) | WO2022109242A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023172858A1 (en) | 2022-03-07 | 2023-09-14 | Amgen Inc. | A process for preparing 4-methyl-2-propan-2-yl-pyridine-3-carbonitrile |
| CN115466259B (zh) * | 2022-08-16 | 2023-12-05 | 山东大学 | 一种kras g12c抑制剂索托拉西布的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190272A1 (ar) * | 2017-05-22 | 2019-11-21 | Amgen Inc | مثبطات kras g12c وطرق لاستخدامها |
| IL272512B (en) * | 2017-09-08 | 2022-07-01 | Amgen Inc | kras g12c inhibitors and methods of using them |
| JP7516029B2 (ja) | 2018-11-16 | 2024-07-16 | アムジエン・インコーポレーテツド | Ｋｒａｓ ｇ１２ｃ阻害剤化合物の重要な中間体の改良合成法 |
| TW202132271A (zh) | 2019-11-14 | 2021-09-01 | 美商安進公司 | Ｋｒａｓ ｇ１２ｃ抑制劑化合物之改善的合成 |
| TW202132296A (zh) | 2019-11-14 | 2021-09-01 | 美商安進公司 | Ｋｒａｓ ｇ１２ｃ抑制劑化合物之改善的合成 |
-
2021
- 2021-11-19 US US18/253,285 patent/US20240025896A1/en active Pending
- 2021-11-19 CN CN202180077757.9A patent/CN116507624A/zh active Pending
- 2021-11-19 CA CA3201663A patent/CA3201663A1/en active Pending
- 2021-11-19 TW TW110143100A patent/TW202237598A/zh unknown
- 2021-11-19 JP JP2023529991A patent/JP2023550386A/ja active Pending
- 2021-11-19 WO PCT/US2021/060048 patent/WO2022109242A1/en active Application Filing
- 2021-11-19 MX MX2023005823A patent/MX2023005823A/es unknown
- 2021-11-19 AR ARP210103204A patent/AR124105A1/es unknown
- 2021-11-19 AU AU2021382674A patent/AU2021382674A1/en active Pending
- 2021-11-19 KR KR1020237020849A patent/KR20230110575A/ko unknown
- 2021-11-19 IL IL302821A patent/IL302821A/en unknown
- 2021-11-19 EP EP21827309.2A patent/EP4247813A1/en active Pending
-
2023
- 2023-05-18 CL CL2023001439A patent/CL2023001439A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021382674A1 (en) | 2023-06-22 |
| US20240025896A1 (en) | 2024-01-25 |
| JP2023550386A (ja) | 2023-12-01 |
| KR20230110575A (ko) | 2023-07-24 |
| CA3201663A1 (en) | 2022-05-27 |
| CN116507624A (zh) | 2023-07-28 |
| TW202237598A (zh) | 2022-10-01 |
| EP4247813A1 (en) | 2023-09-27 |
| MX2023005823A (es) | 2023-05-31 |
| AR124105A1 (es) | 2023-02-15 |
| AU2021382674A9 (en) | 2024-04-18 |
| IL302821A (en) | 2023-07-01 |
| WO2022109242A1 (en) | 2022-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023001439A1 (es) | Procedimiento para preparar 7-cloro-6-fluoro-1-(2-isopropil-4-metilpiridin-3-il)pirido[2,3-d]pirimidino-2,4(1h,3h)-diona | |
| CL2019001077A1 (es) | Derivados de 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f] isoquinolina útiles en el tratamiento del cáncer. | |
| CO2022006858A2 (es) | Inhibidores de pequeñas moléculas de mutante g12c de kras | |
| CY1120342T1 (el) | Ανταγωνιστης πολυκυκλικου lpa1 και χρησεις εξ' αυτου | |
| WO2020257549A3 (en) | Compounds for treatment of pd-l1 diseases | |
| AR047531A1 (es) | Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa | |
| ECSP066361A (es) | Derivados de piperazina | |
| UY29277A1 (es) | Derivados de benzamidas (4(4-(1-isopropil-2-metil-1h-imidazol-5-il)-pirimidin-2-il)amino)sustitudas, composiciones que los contienen, procedimiento de preparación y aplicaciones | |
| CN114727974A (zh) | Hdac6抑制剂及其用途 | |
| UY29427A1 (es) | Derivados sustituidos de 2,3,4,5- tetrahidro-1h-pirido (4,3-b) indol, composiciones que los contienen, procesos de preparación y aplicaciones | |
| RS54166B1 (en) | IMIDASO [1,2-A] Pyridine derivatives as FGFR kinase inhibitors for use in therapy | |
| CL2021001396A1 (es) | Derivados de panteteína y usos de los mismos | |
| IL202600A0 (en) | Azaindole-indole coupled derivatives, preparation methods and uses thereof | |
| Racine et al. | Direct N-cyclopropylation of secondary acyclic amides promoted by copper | |
| AR109990A1 (es) | Derivados de imidazopirazinonas inhibidores de pde1 | |
| WO2020097400A8 (en) | Imidazopyridine derivatives and aza-imidazopyridine derivatives as janus kinase 2 inhibitors and uses thereof | |
| CO2023007677A2 (es) | Derivados de pyrazolo[1,5-a]pirazina como inhibidores de la btk | |
| AR045159A1 (es) | Derivados de 1-sulfonilindoles, su preparacion y su aplicacion como medicamentos | |
| AR057067A1 (es) | Procedimiento para preparar sales de tiotropio, sales de tiotropio como tales y composiciones farmaceuticas de las mismas | |
| CL2022000893A1 (es) | Derivados de 2-azaspiro[3,4]octano como agonistas de m4 | |
| AR072591A1 (es) | Nitratos de isosorbida, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades vasculares. | |
| SE7906287L (sv) | Nya indol-(2,3-a)-kinolizidiner, sett att framstella dessa och deras anvendning som terapeutika | |
| UY29801A1 (es) | Derivados de quinazolina, sales farmacéuticamente aceptables de las mismas, composiciones farmacéuticas conteniéndolas, procedimientos de preparación y aplicaciones. | |
| MX2022010673A (es) | Nuevos compuestos macrociclicos, un proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| GB1415471A (en) | Phenylethylamine derivatives |